Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.

Abstract

Obstetric practice is evolving; the future will see a shift in the focus of care to the pre-conceptual period and early trimester with a move towards interventions which optimize maternal and neonatal outcome. 1 Low dose Aspirin (LDA) is one such intervention. The safety and efficacy of this medicinal product has already been proven 2,3 and subsequently it is now used common in practice for at-risk pregnancies for prevention of pre-eclampsia, fetal growth restriction and complications of anti-phospholipid syndrome.